Jeffrey Bailey

Jeffrey Bailey

Direttore/Membro del Consiglio presso AURINIA PHARMACEUTICALS INC.

Patrimonio netto: 349 141 $ in data 31/05/2026

64 anni
Health Technology
Miscellaneous
Finance

Profilo

Jeffrey Allen Bailey is Director at Madison Vaccines, Inc. since 2017.
Independent Director at Aurinia Pharmaceuticals, Inc. and Director at Aberdeen Investments LLC since 2023.
Independent Trustee at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund since 2020.
Former Chief Executive Officer & Director at BioDelivery Sciences International, Inc. from 2020 to 2022.
Former Chief Executive Officer & Director at IlluminOss Medical, Inc. from 2018 to 2020.
Former Chairman at Tekla Capital Management LLC from 2020 to 2023.
Former Chairman at Rein Therapeutics, Inc. from 2018 to 2023.
Former Executive Chairman & Chief Executive Officer at Neurovance, Inc. from 2015 to 2017.
Former President, Chief Executive Officer & Director at Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. from 2013 to 2015.
Former Director at Biodelivery Systems, Inc. from 2020 to 2022.
Former Chief Operating Officer at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
Former Chief Commercial Officer at KP Pharmaceuticals LLC from 2010 to 2011.
Former President & GM-Northwest Operating Unit at Novartis Pharmaceuticals Corp.
and President & General Manager at Novartis AG from 2008 to 2010.
Former Vice President-Sales at Johnson & Johnson from 1984 to 2004.
Former Independent Director at Landauer, Inc. and Director at ImaginAb, Inc. Former Vice President-Marketing at Mainevest LLC.
Education includes undergraduate degree from Rutgers State University of New Jersey.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
04/06/2026 22.775 ( 0,02% ) 349 141 $ 31/05/2026

Posizioni attive di Jeffrey Bailey

SocietàPosizioneInizio
ABRDN WORLD HEALTHCARE FUND Direttore/Membro del Consiglio 01/01/2020
ABRDN HEALTHCARE INVESTORS Direttore/Membro del Consiglio 01/01/2020
ABRDN LIFE SCIENCES INVESTORS Direttore/Membro del Consiglio 01/01/2020
ABRDN HEALTHCARE OPPORTUNITIES FUND Direttore/Membro del Consiglio 01/01/2020
AURINIA PHARMACEUTICALS INC. Direttore/Membro del Consiglio 18/08/2023
Direttore/Membro del Consiglio 01/01/2023
Direttore/Membro del Consiglio 27/10/2017

Precedenti posizioni note di Jeffrey Bailey

SocietàPosizioneFine
REIN THERAPEUTICS INC. Presidente 31/10/2023
Presidente 01/01/2023
░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Jeffrey Bailey

Formazione di Jeffrey Bailey

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

76

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private24

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Miscellaneous

Miscellaneous

Miscellaneous

Miscellaneous

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Mainevest LLC

Health Technology

Health Technology

Health Technology

Finance

Biodelivery Systems, Inc.

  1. Mercati
  2. Insiders
  3. Jeffrey Bailey